Bill Text: US HB2276 | 2011-2012 | 112th Congress | Introduced
Bill Title: To require the Director of the United States Patent and Trademark Office to conduct a study on effective ways to provide confirming genetic diagnostic test activity where gene patents and exclusive licensing exist, and for other purposes.
Sponsorship: Partisan Bill (Democrat 1)
Status: (Introduced - Dead) 2011-08-25 - Referred to the Subcommittee on Intellectual Property, Competition and the Internet. [HB2276 Detail]
Download: US_Congress-2011-HB2276-Introduced.pdf
